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in NHC. There was a trend toward increased CAS utilization over time among
NHC and OG, and a trend toward increased CEA utilization among H and
AA.TCT-508
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Background: The research investigates the possibility of reducing cognitive disorders
and restoring activities of daily living in patients after extensive ischemic stroke using
transcatheter cerebral revascularization.
Methods: 92 patients aged 32-72 having undergone extensive ischemic stroke
spreading to different parts of the brain were examined. The patients underwent:
Index Bartels (IB), CT, brain MRI, scintigraphy (SG), rheoencephalography (REG),
MUGA. 68 patients underwent transcatheter treatment - Test Group. 24 patients
underwent conservative treatment - Control Group. High-energy pulsed laser
systems were used for revascularization of the major intracranial arteries; low-energy
continuous laser systems were used for revascularization of the distal intracranial
branches.
Results: Test Group. 66 (95.59%) patients had a good immediate angiographic
outcome manifested in the restoration of lumen and patency of the affected vessels
as well as in collateral revascularization. 12-24 months later the following positive
dynamics was observed: good clinical outcome (almost complete intellectual abilities
and motor functions restoration - IB90-100) - 14 (20.59%) patients; satisfactory
clinical outcome (incomplete intellectual abilities and motor functions restoration -
IB75-85) - 30 (44.12%) patients; relatively satisfactory clinical outcome (partial
intellectual abilities and motor functions restoration - IB60-70) - 24 (35.29%)
patients; relatively positive clinical outcome (absence of negative dynamics with
insigniﬁcant restoration of motor functions – IB<60) was not obtained in any case.
Control Group. 12-24 months later the following dynamics was observed: good
clinical outcome was not obtained in any case; satisfactory clinical outcome was not
obtained in any case; relatively satisfactory clinical outcome - 4 (16.67%) cases;
relatively positive clinical outcome - 20 (83.33%) cases.
Conclusions: In the treatment of extensive ischemic stroke effects, transcatheter
cerebral revascularization is a more effective method than the therapeutic one. It can
signiﬁcantly reduce the level of cognitive impairment and return patients to active
daily life.P
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mercogliano, ItalyJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrBackground: At present few data exist on the impact on outcome of the use
of different carotid stent types during neuroprotected carotid artery stenting
(CAS). Aim of this study was to evaluate the outcomes associated with neu-
roprotected CAS in selected high volume centers according to different carotid
stent design.
Methods: From January 2007 to December 2007, 1611 patients underwent neuro-
protected CAS in eight European Centers (ERCAS registry). An independent
clinical events committee adjudicated the events. All types of commercially avail-
able carotid stents were used (closed, open and hybrid cell designed). Open cell
designed stent were classiﬁed according to cell free area (< 7.5 mm2 or >7.5
mm2).
Results: 728 closed-cell, 456 hybrid-cell, 234 <7.5 mm2 open-cell, and 193 >7.5
mm2 open-cell stents were implanted. At 30-days 18 strokes occurred (1.12%; 7
(0.96%) in those treated with a closed-cell, 2 (0.44%) in those with a hybrid-cell,
3 (1.28%) in those with a <7.5 mm2 open-cell, and 6 (3.10%) in those treated
with a >7.5 mm2 open-cell stent, p¼0.029). Overall 30 days stroke and death rate
was 1.36%, and no statistically signiﬁcant difference was observed among the
groups.
Conclusions: CAS is a reasonable alternative to carotid endarterectomy as it is
associated with excellent outcomes when performed in well-experienced high
volume centers. Data of the present study suggest that the use of open cell
designed stent with free cell area >7.5 mm2 is associated with an increased 30
days stroke risk. However, future randomized trials are needed to conﬁrm this
ﬁnding.TCT-510
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Background: Some descriptions had shown increased risk for neurological compli-
cations in the case of aortic arch anomalies, bovine arch frequency was 10.2%,
technical failure 12% and complications in 20% of patients. The aim is to compare the
frequency of adverse events in type III arch patients with bovine arch patients in
complex aortic arch (CAA) carotid artery stenting.
Methods: 407 carotid angioplasties with stenting were done. The patients were
divided into two groups: CAA (group 1: 114 patients) and control group (group 2:
293 patients). Patients in the CAA were divided into type III arch (group 3: 48
patients) and bovine arch (group 4: 66 patients). The endpoints were the
composite of major cardiovascular adverse events (death, major stroke and
myocardial infarction), major stroke,transitory ischemic attack (TIA) and the
composite of contrast medium nephropathy, haemoglobin dropping more than 2
grs within 24 hours after procedure or complications related to puncture site such
as haematoma, pseudoaneurysm or arterio venous ﬁstula, called "other adverse
events".
Results: The rate of TIA was a little higher in the CAA group 2.63% (p¼0.022),
compared with control, because of the higher rate in the type III group (4.1% p¼
0.003). For the endpoint "other adverse events" there were more events in the CAA
group (12 patients 10.52% p¼ 0.022), but this depends on a signiﬁcantly higher
frequency of events in the type III group (8 patients 16.6% of the type III p¼ 0.001).
At 30 days follow up there were increases in the frequency of major stroke and TIA in
the CAA group (4.3% and 2.63% of group 1, p¼ 0.023 and 0.022). These events were
more frequent in group 3 (type III) 4.16% for both endpoints p¼ 0.108 for major stoke
and 0.038 for TIA.
Conclusions: There were signiﬁcantly more periprocedural adverse events in the
CAA group in the endpoint of "other adverse events" and TIA. In these two cases,
most events were in the type III aortic arch group. The aortic arch type III seems
to be responsible for most adverse events in the carotid stenting of the CAA
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